#$217.00

[moneyhealthfinance-blog]

Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wedbush with a $217.00 price target

Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wedbush with a $217.00 price target

Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wedbush with a $ 217.00 price target

Mar 07, 2019 (Market Exclusive via COMTEX) —

Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)

Today, Wedbush reiterated its Outperform rating on Ascendis Pharma A/S (NASDAQ:ASND) with a price target of $ 217.00.

There are 8 Buy Ratings,…

View On WordPress